Bayer's radium-223 dichloride plus enzalutamide demonstrates significant overall survival benefit in the PEACE-3 trial in patients with metastatic castration-resistant prostate cancer with bone metastases ... About Xofigo™(radium-223 dichloride).
Results from PEACE-3 show that starting with a combination of radium-223 and enzalutamide, may help support treatment strategies that prioritize bone health ... About XOFIGO® (radium-223 dichloride) Injection2.
The SouthKorean government has announced plans to invest KRW 321 billion ($222.6 million) in 2026 to upgrade regional distribution networks, deploy 85 energy storage systems, and expand solar integration while piloting microgrids and market reforms.
CEOPhilip M. Arlen, MD gives a Keynote presentation describing in vitro and in vivo efficacy of its novel tumor-specific antibody-drug-conjugate PB-223 ADC (PB-vcMMAE-5) ... "PB-223, A Novel ...
). 12 Feb 2026 18.00 CET. Subscribe. Nom de l'emetteur. JACQUET METALS. Regulatory News.. JACQUET METALS SA (Paris.JCQ) .. Date. Nombre d'actions composant le capital. Nombre de droits de vote théoriques. 31 janvier 2026 ...Source ... Fournisseur.